Lv11
10 积分 2024-08-12 加入
Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study
5小时前
待确认
TRIM超家族蛋白在慢性肝病和肝细胞癌中的进展
1个月前
已完结
Regulation of NLRP3/TRIM family signaling in gutinflammation and colorectal cancer
1个月前
已完结
Surufatinib: First Approval
2个月前
已完结
Bile metabolic fingerprints distinguish biliary tract cancer from benign biliary diseases
2个月前
已完结
Macro CD5L deteriorates CD8T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma ++
3个月前
已完结
Hepatic arterial infusion chemotherapy combined with bevacizumab plus a PD-1 inhibitor for gallbladder cancer with hepatic oligometastasis: a real-world study
3个月前
已完结
Tumor-derived CD109 orchestrates reprogramming of tumor-associated macrophages to dampen immune response
4个月前
已完结
Diagnostic efficacy of an extracellular vesicle-derived lncRNA-based liquid biopsy signature for the early detection of early-onset gastric cancer
6个月前
已完结
皖公网安备34019202002308
